Table 4.

Days until loss of discomfort

	Median	Mean (SD)
Viroxyn and Abreva users
Control	6.0	6.7 (3.5)*
Abreva	3.0	2.8 (2.1)†
Viroxyn	0.042	0.6 (1.0)‡
	(1 hour)	(14.4 hours)
N = 180
Viroxyn only users
Control	5.0	6.3 (3.7)
Viroxyn	0.052	0.007 (1.2)†
	(1.3 hours)	(10 minutes)
N = 58

Definition: consistent categorization of pain as being mild-none.

^*Control versus Abreva (t-test; p < 0.001).

^†Control versus Viroxyn (t-test; p < 0.001).

^‡Viroxyn versus Abreva (t-test; p < 0.001).